Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

RZLT

Rezolute, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1509261Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2026
—
Net Income FY2026
$(78.0M)
EPS (Basic, as reported)
$-0.75
Net Margin FY2026
—
ROE FY2026
-77.1%
Total Equity
$101.0M
Shares Out
97M
Business description

Rezolute, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itNet income: (20) → (78)
Fiscal yearFY2017FY2018FY2019FY2020FY2021⚑FY2022⚑FY2023FY2024⚑FY2025FY2026
Research & development(12)(17)(19)(14)(15)(32)(44)(56)(62)(54)
General & administrative(8)(11)(7)(6)(8)(9)(12)(15)(18)(29)
Total operating expenses(20)(29)(26)(21)(23)(42)(56)(70)(80)(83)
Operating income(20)(29)(26)(21)(23)(42)(56)(70)(80)(83)
Interest expense0(1)(5)00—————
Interest & investment income00————————
Other income (expense), net0(1)(5)021425—
Income tax expense0000000000
Net income(20)(30)(30)(20)(21)(41)(52)(68)(74)(78)
EPS — basic————($2.72)($2.26)($1.01)($1.33)($0.98)($0.75)
EPS — diluted————($2.72)($2.32)($1.01)($1.33)($0.98)($0.75)
Shares outstanding — basic (M)————818515176104
Shares outstanding — diluted (M)————819515176104

Showing the latest 10 of 16 fiscal years.

  • ⚑ Weighted-average shares changed ×2.25 between FY2021 and FY2022 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.83 between FY2022 and FY2023 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.49 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.